Academic conference presentation
1.
2025/10/05
Digitally Vulnerable Groups: Promoting Inclusive Digital Health Literacy
2.
2024/05
Result of the questionnaire survey on diversity, equity, and inclusion (DE & I) by the diversity promotion committee of the Japanese Society of Myeloma
3.
2020/07
A Hereditary bleeding disorder caused by a novel homozygous mutation of thrombomodulin gene
(ISTH Congress（Milan, Italy）)
4.
2018/12
Immunomodulatory Effects of Proteasome Inhibitors in Multiple Myeloma
(ASH 60th Annual Meeting（San Diego, USA）)
5.
2018/07
Identification of clonal evolution of CSF3R -mutated chronic neutrophilic leukemia using mutational screens of SETBP1 , ASXL1 and SRSF2
(9th JSH International Symposium（Kyoto, Japan）)
6.
2013/08
Primary HER2-positive lacrimal sac cancer
7.
2013/06
Plasmodium Ovale malaria in a Japanese volunteer returning from Uganda
8.
2013/03
Analysis of short-term survivors after autologous stem cell transplantation in multiple myeloma
9.
2012/10
Successful treatment of APL in a patient with hepatocellular carcinoma using arsenic trioxide
10.
2011/03
Primary amyloidosis involving congestive heart failure with 7-year survival after high-dose melphalan followed by autologous stem cell transplantation
11.
2003/03
Inhibitors of Sir2p: evaluation of Splitomicin analogues
(225th ACS National Meeting（New Orleans, USA）)
12.
2003/02
Chemical genetics of NAD+-dependent protein deacetylases
(12th Volcano Conf. in Bioorganic Chemistry（Eatonville, USA）)